Universe Pharmaceuticals INC (UPC)
USD 4.73
(-3.07%)
USD 4.73
(-3.07%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 32.3 Million USD | -19.52% |
| 2022 | 40.14 Million USD | -16.34% |
| 2021 | 47.98 Million USD | 56.27% |
| 2020 | 30.7 Million USD | -7.6% |
| 2019 | 33.22 Million USD | 16.54% |
| 2018 | 28.51 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 12.88 Million USD | 0.0% |
| 2023 Q4 | 13.84 Million USD | 0.0% |
| 2023 FY | 32.3 Million USD | -19.52% |
| 2023 Q2 | 18.46 Million USD | 0.0% |
| 2022 Q4 | 15.94 Million USD | 0.0% |
| 2022 FY | 40.14 Million USD | -16.34% |
| 2022 Q2 | 24.2 Million USD | 0.0% |
| 2021 FY | 47.98 Million USD | 56.27% |
| 2021 Q2 | 24.29 Million USD | 0.0% |
| 2021 Q4 | 23.68 Million USD | 0.0% |
| 2020 Q4 | 7.67 Million USD | 0.0% |
| 2020 FY | 30.7 Million USD | -7.6% |
| 2020 Q3 | 7.67 Million USD | 0.0% |
| 2020 Q2 | 7.67 Million USD | 0.0% |
| 2020 Q1 | 7.67 Million USD | -7.6% |
| 2019 Q2 | 8.3 Million USD | 0.0% |
| 2019 FY | 33.22 Million USD | 16.54% |
| 2019 Q4 | 8.3 Million USD | 0.0% |
| 2019 Q3 | 8.3 Million USD | 0.0% |
| 2018 Q3 | 7.12 Million USD | 0.0% |
| 2018 Q4 | 7.12 Million USD | 0.0% |
| 2018 Q2 | 7.12 Million USD | 0.0% |
| 2018 FY | 28.51 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 116.33 Million USD | 72.228% |
| Theratechnologies Inc. | 81.76 Million USD | 60.485% |
| Safety Shot Inc | 202.67 Thousand USD | -15841.548% |
| Cosmos Health Inc. | 53.37 Million USD | 39.471% |
| Cronos Group Inc. | 88.84 Million USD | 63.633% |
| Ironwood Pharmaceuticals, Inc. | 442.73 Million USD | 92.702% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| Organogenesis Holdings Inc. | 433.14 Million USD | 92.541% |
| ProPhase Labs, Inc. | 44.38 Million USD | 27.206% |
| Sonoma Pharmaceuticals, Inc. | 12.73 Million USD | -153.7% |
| Dynavax Technologies Corporation | 232.28 Million USD | 86.091% |
| Radius Health, Inc. | 2.88 Billion USD | 98.879% |
| China SXT Pharmaceuticals, Inc. | 1.92 Million USD | -1575.332% |
| Alvotech | 91.43 Million USD | 64.664% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -34.101% |
| Alpha Teknova, Inc. | 36.68 Million USD | 11.927% |
| Intra-Cellular Therapies, Inc. | 464.37 Million USD | 93.042% |
| SCYNEXIS, Inc. | 140.14 Million USD | 76.946% |
| Harrow Health, Inc. | 130.19 Million USD | 75.184% |
| Biofrontera Inc. | 34.07 Million USD | 5.172% |
| DURECT Corporation | 8.54 Million USD | -277.968% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | 94.682% |
| ANI Pharmaceuticals, Inc. | 486.81 Million USD | 93.363% |
| OptiNose, Inc. | 70.98 Million USD | 54.486% |
| RedHill Biopharma Ltd. | 6.51 Million USD | -396.052% |
| Aquestive Therapeutics, Inc. | 50.58 Million USD | 36.127% |
| Cumberland Pharmaceuticals Inc. | 39.55 Million USD | 18.314% |
| SIGA Technologies, Inc. | 139.91 Million USD | 76.909% |
| Lifecore Biomedical, Inc. | 128.26 Million USD | 74.81% |
| Shineco, Inc. | 9.8 Million USD | -229.619% |
| Phibro Animal Health Corporation | 1.01 Billion USD | 96.825% |
| Procaps Group S.A. | 409.92 Million USD | 92.118% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -2381.47% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Viatris Inc. | 15.42 Billion USD | 99.791% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -34.101% |
| Rockwell Medical, Inc. | 83.61 Million USD | 61.359% |
| Incannex Healthcare Limited | 12 Thousand USD | -269139.458% |
| Aytu BioPharma, Inc. | 81 Million USD | 60.114% |
| Tilray Brands, Inc. | 788.94 Million USD | 95.905% |
| Collegium Pharmaceutical, Inc. | 566.76 Million USD | 94.299% |
| PetIQ, Inc. | 1.1 Billion USD | 97.068% |
| Silver Spike Investment Corp. | 11.72 Million USD | -175.622% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | 98.288% |
| Journey Medical Corporation | 79.18 Million USD | 59.196% |
| Alimera Sciences, Inc. | 80.75 Million USD | 59.991% |
| Petros Pharmaceuticals, Inc. | 5.82 Million USD | -454.905% |
| Assertio Holdings, Inc. | 152.06 Million USD | 78.754% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Embecta Corp. | 1.12 Billion USD | 97.117% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -2901.541% |
| Procaps Group, S.A. | 409.92 Million USD | 92.118% |
| PainReform Ltd. | - USD | -Infinity% |
| Avadel Pharmaceuticals plc | 27.96 Million USD | -15.541% |
| Hempacco Co., Inc. | 4.04 Million USD | -698.607% |
| Talphera, Inc. | 651 Thousand USD | -4862.939% |
| Pacira BioSciences, Inc. | 674.97 Million USD | 95.213% |
| Alvotech | 91.43 Million USD | 64.664% |
| Lantheus Holdings, Inc. | 1.29 Billion USD | 97.508% |
| Kamada Ltd. | 144.75 Million USD | 77.681% |
| Indivior PLC | 1.09 Billion USD | 97.044% |
| Currenc Group, Inc. | 53.25 Million USD | 39.332% |
| Evoke Pharma, Inc. | 5.18 Million USD | -523.645% |
| Flora Growth Corp. | 76.07 Million USD | 57.528% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -2901.541% |
| Evolus, Inc. | 202.08 Million USD | 84.012% |
| HUTCHMED (China) Limited | 837.99 Million USD | 96.145% |
| Amphastar Pharmaceuticals, Inc. | 644.39 Million USD | 94.986% |
| Akanda Corp. | 2.16 Million USD | -1395.739% |